Gary Charles Robb sold $173k of CORT
Chief Business Officer at CORCEPT THERAPEUTICS INC. 2,279 shares at an average of $75.85, traded May 20, 2025, filed May 22, 2025.
Score components
- +15RoleOfficer
- +11Trade size$173k at market
- +5Share of holdings soldSold 12% of holdings
- +15Cluster7 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-076417, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 20, 2025 | SOpen-market sale Common Stock | -2,279 | $75.85 | $173k | 16,586 | May 22, 2025 |
| May 20, 2025 | GGift Common Stock | -1,380 | $0.00 | $0 | 15,206 | May 22, 2025 |
| May 20, 2025 | GGift Common Stockindirect: Custodial Account for Child | +360 | $0.00 | $0 | 11,571 | May 22, 2025 |
| May 20, 2025 | GGift Common Stockindirect: Custodial Account for Child | +360 | $0.00 | $0 | 11,571 | May 22, 2025 |
Related signals
Other insiders at CORCEPT THERAPEUTICS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | CORCEPT THERAPEUTICS INC | Sean Maduck See Remarks | $2.9M 25,000 shares | -242% | |
| 40Moderate | CORCEPT THERAPEUTICS INC | Joseph Douglas Lyon See Remarks | $1.2M 10,000 shares | -154% | |
| 45Moderate | CORCEPT THERAPEUTICS INC | Roberto Wandenkolk Vieira President, Oncology | $967k 8,333 shares | -68% | |
| 20Weak | CORCEPT THERAPEUTICS INC | Roberto Wandenkolk Vieira President, Oncology | $30k 296 shares | -7% | |
| 35Weak | CORCEPT THERAPEUTICS INC | James N Wilson director | $1.1M 10,000 shares | -1% | |
| 40Moderate | CORCEPT THERAPEUTICS INC | Joseph Douglas Lyon See Remarks | $1.1M 10,000 shares | -64% | |
| 45Moderate | CORCEPT THERAPEUTICS INC | Roberto Wandenkolk Vieira President, Oncology | $6.5M 58,333 shares | -93% | |
| 40Moderate | CORCEPT THERAPEUTICS INC | Sean Maduck See Remarks | $2.9M 25,000 shares | -72% | |
| 45Moderate | CORCEPT THERAPEUTICS INC | Joseph K Belanoff Chief Executive Officer | $3.2M 40,000 shares | -1% | |
| 21Weak | CORCEPT THERAPEUTICS INC | Joseph Douglas Lyon See Remarks | $398k 5,000 shares | -33% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.